Serial Number | 86577541 |
Word Mark | HEPTARES |
Filing Date | Thursday, March 26, 2015 |
Status | 705 - PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED |
Status Date | Tuesday, January 2, 2024 |
Registration Number | 5239010 |
Registration Date | Tuesday, July 11, 2017 |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 25, 2017 |
Goods and Services | [ Biological products for medical purposes, namely, g-protein-coupled receptors, transmembrane proteins and parts thereof for use in chemical and biological drug discovery, lead identification, diagnostics and therapeutic purposes; biological and chemical products for medical use, namely, proteins, G-protein-coupled receptors, transmembrane proteins, G-Proteins, antibodies and peptides and parts thereof, for therapeutic purposes; chemicals, proteins and parts thereof for use in medical diagnostics; none being dietetic substances adapted for medical use or food products ] |
Translation of Words in Mark | The wording "HEPTARES" has no meaning in a foreign language. |
Goods and Services | [ Chemicals and proteins used in research, namely, for chemistry and biological drug discovery, lead identification and diagnostics; proteins including G-protein-coupled receptors, trans-membrane proteins and parts thereof, for use in pharmaceutical research, namely, drug discovery purposes ] |
Goods and Services | Pharmaceutical advice; pharmaceutical consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; research, creation, development and provision of chemical and biological drug targets for medical screening purposes |
Goods and Services | Biotechnology testing, namely, genetic testing for scientific research purposes; Biotechnology research; Biotechnology development, namely, development in the field of drug discovery and biopharmaceuticals; biotechnology advice; Biotechnology consultancy; Biotechnology information, namely, providing information on the subject of scientific research in the field of biotechnology; Pharmaceutical testing; pharmaceutical research; pharmaceutical development; pharmaceutical consultancy for non-medical purposes; Providing medical and scientific research information in the fields of pharmaceuticals; scientific testing and research in the pharmaceutical and biopharmaceutical fields, namely, chemical and biological drug discovery services; providing scientific information, advice, and consultancy in the field of technologies related to proteins, including transmembrane proteins and G-proteins, and G protein coupled receptors, and parts thereof; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; Research and development in the pharmaceutical and biopharmaceutical fields, namely, technologies related to proteins and G protein coupled receptors; biology and chemistry services, namely, research and consulting in the field of chemistry and biology; pharmaceutical research services, namely, chemical and biological drug discovery services; research and development services for pharmaceutical lead identification; synthetic chemistry consultation services and research; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research, creation, development and provision of chemical and biological drug targets for non-medical screening purposes; research, analysis and identification of compounds through automated screening processes research and development services relating to pharmaceutical research services, namely, chemical and biological drug discovery services |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | B - Sec. 8 - Class(es) in a Multiple Class registration |
Class Status Date | Tuesday, January 2, 2024 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | B - Sec. 8 - Class(es) in a Multiple Class registration |
Class Status Date | Tuesday, January 2, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, April 4, 2015 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 15, 2016 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | NXERA PHARMA CO., LTD |
Party Type | 32 - New Owner After Registration |
Legal Entity Type | 99 - Other |
Address | TOKYO 107-0052 JP |
Party Name | SOSEI GROUP CORPORATION |
Party Type | 31 - New Owner After Registration |
Legal Entity Type | 03 - Corporation |
Address | TOKYO 102-0083 JP |
Party Name | Heptares Therapeutics Limited |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | Cambridge CB216DG GB |
Party Name | Heptares Therapeutics Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Hertfordshire AL73AX GB |
Party Name | Heptares Therapeutics Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Hertfordshire AL73AX GB |
Event Date | Event Description |
Monday, June 1, 2015 | ASSIGNED TO LIE |
Monday, March 30, 2015 | NEW APPLICATION ENTERED |
Saturday, April 4, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, May 27, 2015 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Friday, June 5, 2015 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
Monday, June 29, 2015 | ASSIGNED TO EXAMINER |
Sunday, July 12, 2015 | NON-FINAL ACTION WRITTEN |
Sunday, July 12, 2015 | NON-FINAL ACTION E-MAILED |
Sunday, July 12, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, January 8, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, January 15, 2016 | ASSIGNED TO LIE |
Wednesday, January 20, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, January 20, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, January 20, 2016 | REPORT UNRESPONSIVE AMENDMENT - COMPLETED |
Wednesday, January 20, 2016 | NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED |
Wednesday, January 20, 2016 | NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED |
Tuesday, February 16, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, February 16, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, February 16, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, March 8, 2016 | FINAL REFUSAL WRITTEN |
Tuesday, March 8, 2016 | FINAL REFUSAL E-MAILED |
Tuesday, March 8, 2016 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Wednesday, June 15, 2016 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Wednesday, June 15, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, June 15, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, July 7, 2016 | SUBSEQUENT FINAL REFUSAL WRITTEN |
Thursday, July 7, 2016 | SUBSEQUENT FINAL EMAILED |
Thursday, July 7, 2016 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
Friday, August 5, 2016 | NON-FINAL ACTION WRITTEN |
Friday, August 5, 2016 | NON-FINAL ACTION E-MAILED |
Friday, August 5, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, February 1, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, February 3, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, February 3, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, March 10, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, March 17, 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Wednesday, April 5, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, April 25, 2017 | PUBLISHED FOR OPPOSITION |
Tuesday, April 25, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 11, 2017 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, October 30, 2018 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Tuesday, October 30, 2018 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Wednesday, May 6, 2020 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Monday, July 11, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Monday, July 10, 2023 | TEAS SECTION 8 & 15 RECEIVED |
Tuesday, January 2, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Tuesday, January 2, 2024 | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
Tuesday, January 2, 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
Thursday, July 4, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |